Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ed J Kuijper

Showing results (31-40 of 250) with videos related to

Pageof 25
Sort By:
The Journal of Antimicrobial Chemotherapy|January 12, 2017
DNA replication proteins as potential targets for antimicrobials in drug-resistant bacterial pathogensErika van Eijk, Bert Wittekoek, Ed J Kuijper, et al.
Journal of Clinical Microbiology|January 8, 2010
High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization-time of flight mass spectrometry in conventional medical microbiology laboratoriesS Q van Veen, E C J Claas, Ed J Kuijper
Advances in Experimental Medicine and Biology|February 1, 2018
Diagnostic Guidance for C. difficile InfectionsMonique J T Crobach, Amoe Baktash, Nikolas Duszenko, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 4, 2016
Clostridium difficile PCR ribotypes 001 and 176 - the common denominator of C. difficile infection epidemiology in the Czech Republic, 2014Marcela Krutova, Jana Matejkova, Ed J Kuijper, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 28, 2013
[New treatment options for infections with Clostridium difficile]Els van Nood, Josbert J Keller, Ed J Kuijper, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 13, 2009
Comparison of molecular typing methods applied to Clostridium difficileEd J Kuijper, Renate J van den Berg, Jon S Brazier
Plos One|November 3, 2012
C. difficile 630Δerm Spo0A regulates sporulation, but does not contribute to toxin production, by direct high-affinity binding to target DNAKatharina E Rosenbusch, Dennis Bakker, Ed J Kuijper, et al.
The Lancet. Microbe|July 25, 2022
International travel, the gut microbiome, and ESBL-E coli carriage - Authors' replyQuinten R Ducarmon, Wiep K Smits, Jelle J Goeman, et al.
Frontiers in Microbiology|July 11, 2018
Application of Antibody-Mediated Therapy for Treatment and Prevention of <i>Clostridium difficile</i> InfectionBeatrix Förster, Pui Khi Chung, Monique J T Crobach, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 7, 2008
Laboratory-acquired clostridium difficile polymerase chain reaction ribotype 027: a new risk for laboratory workers?Emilio Bouza, Adoración Martin, Renata J Van den Berg, et al.
Pageof 25

Showing results (31-40 of 250) with videos related to

Sort By:
Pageof 25
The Journal of Antimicrobial Chemotherapy|January 12, 2017
DNA replication proteins as potential targets for antimicrobials in drug-resistant bacterial pathogensErika van Eijk, Bert Wittekoek, Ed J Kuijper, et al.
Journal of Clinical Microbiology|January 8, 2010
High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization-time of flight mass spectrometry in conventional medical microbiology laboratoriesS Q van Veen, E C J Claas, Ed J Kuijper
Advances in Experimental Medicine and Biology|February 1, 2018
Diagnostic Guidance for C. difficile InfectionsMonique J T Crobach, Amoe Baktash, Nikolas Duszenko, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 4, 2016
Clostridium difficile PCR ribotypes 001 and 176 - the common denominator of C. difficile infection epidemiology in the Czech Republic, 2014Marcela Krutova, Jana Matejkova, Ed J Kuijper, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 28, 2013
[New treatment options for infections with Clostridium difficile]Els van Nood, Josbert J Keller, Ed J Kuijper, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 13, 2009
Comparison of molecular typing methods applied to Clostridium difficileEd J Kuijper, Renate J van den Berg, Jon S Brazier
Plos One|November 3, 2012
C. difficile 630Δerm Spo0A regulates sporulation, but does not contribute to toxin production, by direct high-affinity binding to target DNAKatharina E Rosenbusch, Dennis Bakker, Ed J Kuijper, et al.
The Lancet. Microbe|July 25, 2022
International travel, the gut microbiome, and ESBL-E coli carriage - Authors' replyQuinten R Ducarmon, Wiep K Smits, Jelle J Goeman, et al.
Frontiers in Microbiology|July 11, 2018
Application of Antibody-Mediated Therapy for Treatment and Prevention of <i>Clostridium difficile</i> InfectionBeatrix Förster, Pui Khi Chung, Monique J T Crobach, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 7, 2008
Laboratory-acquired clostridium difficile polymerase chain reaction ribotype 027: a new risk for laboratory workers?Emilio Bouza, Adoración Martin, Renata J Van den Berg, et al.
Pageof 25